PMID-sentid	Pub_year	Sent_text	comp_official_name	comp_offset	protein_name	organism	prot_offset
1664856-6	1991	The results suggest that increases in cAMP contents and synthesis of an extracellular, hyaluronidase-sensitive mucus by pig OCC and C + P induced by FSH or forskolin are not dependent on the oocyte.	Colforsin	156-165	hemopexin	Sus scrofa	87-100
3342340-5	1988	The resulting extract contained uronic acid, and after electrophoresis on Super Sepraphore revealed 2 bands: One co-migrated with heparan sulfate standard, the other with chondroitin sulfate A and C. The first was completely eliminated by nitrous acid and heparitinase, but not by hyaluronidase or chondroitinase ABC and was therefore confirmed as heparan sulfate; the other band was eliminated by chondroitinase ABC but not by the other three treatments.	Nitrous Acid	239-251	hemopexin	Sus scrofa	281-294
2167067-11	1990	Partial or complete digestions with testicular hyaluronidase (in the presence of an excess of beta-glucuronidase) or chondroitin AC lyase identify the positions of GlcA residues.	Glucuronic Acid	164-168	hemopexin	Sus scrofa	47-60
2167067-14	1990	Results with testicular hyaluronidase indicate that the distribution of clustered GlcA-GalNAc repeats is periodic and peaks at positions 1-3, 8-9 and around 25.	Glucuronic Acid	82-86	hemopexin	Sus scrofa	24-37
2167067-14	1990	Results with testicular hyaluronidase indicate that the distribution of clustered GlcA-GalNAc repeats is periodic and peaks at positions 1-3, 8-9 and around 25.	N-acetylgalactosaminuronic acid	87-93	hemopexin	Sus scrofa	24-37
2358898-4	1990	The enzyme hyaluronidase degrades hyaluronic acid, a constituent of the normal interstitial barrier; by degrading interstitial bonds, it can increase the distribution and absorption of locally injected substances.	Hyaluronic Acid	34-49	hemopexin	Sus scrofa	11-24
2358898-6	1990	Hyaluronidase, in a concentration of 150 U/mL injected subcutaneously in a circumferential fashion immediately following the injection of CaCl2, significantly reduced the area of necrosis (P less than .01).	Calcium Chloride	138-143	hemopexin	Sus scrofa	0-13
2338530-3	1990	In-vitro, degradation products of hyaluronic acid, following its catalysis by hyaluronidase, have been shown to have angiogenic properties.	Hyaluronic Acid	34-49	hemopexin	Sus scrofa	78-91
2338530-9	1990	Hyaluronidase was undetectable in uterine flushings collected on day 15 from corn oil- and oestrogen-treated gilts, but present in similar amounts in uterine flushings from gilts treated with progesterone and progesterone plus oestrogen.	Progesterone	192-204	hemopexin	Sus scrofa	0-13
2338530-9	1990	Hyaluronidase was undetectable in uterine flushings collected on day 15 from corn oil- and oestrogen-treated gilts, but present in similar amounts in uterine flushings from gilts treated with progesterone and progesterone plus oestrogen.	Progesterone	209-221	hemopexin	Sus scrofa	0-13
128355-4	1975	Proteoglycans were then digested exhaustively with testicular hyaluronidase, which removed about 80% of the chondroitin sulphate.	Chondroitin Sulfates	108-128	hemopexin	Sus scrofa	62-75
3970970-5	1985	The substrate specificity of the enzyme was the same as for bovine testicular hyaluronidase; however, both the Km and V values were significantly lower for the pig liver enzyme with all of the substrates tested (hyaluronate, chondroitin 4-sulphate, chondroitin 6-sulphate).	hyaluronate	212-223	hemopexin	Sus scrofa	78-91
3970970-5	1985	The substrate specificity of the enzyme was the same as for bovine testicular hyaluronidase; however, both the Km and V values were significantly lower for the pig liver enzyme with all of the substrates tested (hyaluronate, chondroitin 4-sulphate, chondroitin 6-sulphate).	chondroitin 6-sulphate	249-271	hemopexin	Sus scrofa	78-91
3970970-6	1985	A full kinetic analysis of the enzyme using hyaluronate as a substrate showed that the activity of pig liver hyaluronidase was uncompetitively activated by either protons or NaCl.	hyaluronate	44-55	hemopexin	Sus scrofa	109-122
3970970-6	1985	A full kinetic analysis of the enzyme using hyaluronate as a substrate showed that the activity of pig liver hyaluronidase was uncompetitively activated by either protons or NaCl.	Sodium Chloride	174-178	hemopexin	Sus scrofa	109-122
7283648-4	1981	Depolimerisation of hyaluronic acid by means of hyaluronidase increased the agglutinability of eight strains (14.8 per cent) which could thus be identified by types.	Hyaluronic Acid	20-35	hemopexin	Sus scrofa	48-61
28166932-6	2017	Porcine PBMCs bind to Poly (I:C)-treated cells and this binding is dependent on HA, since the increase in adhesion is abolished by hyaluronidase treatment of the cell layers.	Poly I	22-30	hemopexin	Sus scrofa	131-144
1156366-9	1975	To determine the location of L-IdUA-SO4 residues along the copolymeric chain dermatan sulphate was digested with testicular hyaluronidase.	l-idua-so4	29-39	hemopexin	Sus scrofa	124-137
1156366-9	1975	To determine the location of L-IdUA-SO4 residues along the copolymeric chain dermatan sulphate was digested with testicular hyaluronidase.	Dermatan Sulfate	77-94	hemopexin	Sus scrofa	124-137
1156366-15	1975	To study the distribution of L-IdUA-SO4-containing periods in relation to blocks of IdUA-GalNAc-SO4 periods different fractions of hyaluronidase-degraded dermatan sulphate were degraded separately.	Dermatan Sulfate	154-171	hemopexin	Sus scrofa	131-144
1156366-21	1975	An octasaccharide derived from the carbohydrate sequence -GalNAc---GlcUA-GalNAc-IdUA-GalNAc-GlcUA-GalNAc-IdUA-GalNAc---GlcUA-GalNAc (--- indicates the position of cleavage by hyaluronidase) was identified.	Octasaccharide	3-17	hemopexin	Sus scrofa	175-188
1156366-21	1975	An octasaccharide derived from the carbohydrate sequence -GalNAc---GlcUA-GalNAc-IdUA-GalNAc-GlcUA-GalNAc-IdUA-GalNAc---GlcUA-GalNAc (--- indicates the position of cleavage by hyaluronidase) was identified.	Carbohydrates	35-47	hemopexin	Sus scrofa	175-188
1156366-21	1975	An octasaccharide derived from the carbohydrate sequence -GalNAc---GlcUA-GalNAc-IdUA-GalNAc-GlcUA-GalNAc-IdUA-GalNAc---GlcUA-GalNAc (--- indicates the position of cleavage by hyaluronidase) was identified.	N-acetylgalactosaminuronic acid	58-64	hemopexin	Sus scrofa	175-188
1156366-21	1975	An octasaccharide derived from the carbohydrate sequence -GalNAc---GlcUA-GalNAc-IdUA-GalNAc-GlcUA-GalNAc-IdUA-GalNAc---GlcUA-GalNAc (--- indicates the position of cleavage by hyaluronidase) was identified.	glcua	67-72	hemopexin	Sus scrofa	175-188
1156366-21	1975	An octasaccharide derived from the carbohydrate sequence -GalNAc---GlcUA-GalNAc-IdUA-GalNAc-GlcUA-GalNAc-IdUA-GalNAc---GlcUA-GalNAc (--- indicates the position of cleavage by hyaluronidase) was identified.	N-acetylgalactosaminuronic acid	73-79	hemopexin	Sus scrofa	175-188
1156366-21	1975	An octasaccharide derived from the carbohydrate sequence -GalNAc---GlcUA-GalNAc-IdUA-GalNAc-GlcUA-GalNAc-IdUA-GalNAc---GlcUA-GalNAc (--- indicates the position of cleavage by hyaluronidase) was identified.	idua	80-84	hemopexin	Sus scrofa	175-188
1156366-21	1975	An octasaccharide derived from the carbohydrate sequence -GalNAc---GlcUA-GalNAc-IdUA-GalNAc-GlcUA-GalNAc-IdUA-GalNAc---GlcUA-GalNAc (--- indicates the position of cleavage by hyaluronidase) was identified.	N-acetylgalactosaminuronic acid	73-79	hemopexin	Sus scrofa	175-188
1156366-21	1975	An octasaccharide derived from the carbohydrate sequence -GalNAc---GlcUA-GalNAc-IdUA-GalNAc-GlcUA-GalNAc-IdUA-GalNAc---GlcUA-GalNAc (--- indicates the position of cleavage by hyaluronidase) was identified.	glcua	92-97	hemopexin	Sus scrofa	175-188
1156366-21	1975	An octasaccharide derived from the carbohydrate sequence -GalNAc---GlcUA-GalNAc-IdUA-GalNAc-GlcUA-GalNAc-IdUA-GalNAc---GlcUA-GalNAc (--- indicates the position of cleavage by hyaluronidase) was identified.	N-acetylgalactosaminuronic acid	73-79	hemopexin	Sus scrofa	175-188
1156366-21	1975	An octasaccharide derived from the carbohydrate sequence -GalNAc---GlcUA-GalNAc-IdUA-GalNAc-GlcUA-GalNAc-IdUA-GalNAc---GlcUA-GalNAc (--- indicates the position of cleavage by hyaluronidase) was identified.	N-acetylgalactosaminuronic acid	73-79	hemopexin	Sus scrofa	175-188
4376944-2	1974	Dermatan sulphate was degraded by testicular hyaluronidase and an oversulphated fraction was isolated by ion-exchange chromatography.	Dermatan Sulfate	0-17	hemopexin	Sus scrofa	45-58
31468717-4	2019	In this design, HAase is encapsulated on the surfaces of doxorubicin (DOX) preloaded ZnO-DOX NPs using a charge convertible polymer PEG-PAH-DMMA (ZDHD).	Doxorubicin	57-68	hemopexin	Sus scrofa	16-21
31468717-4	2019	In this design, HAase is encapsulated on the surfaces of doxorubicin (DOX) preloaded ZnO-DOX NPs using a charge convertible polymer PEG-PAH-DMMA (ZDHD).	Doxorubicin	70-73	hemopexin	Sus scrofa	16-21
31468717-4	2019	In this design, HAase is encapsulated on the surfaces of doxorubicin (DOX) preloaded ZnO-DOX NPs using a charge convertible polymer PEG-PAH-DMMA (ZDHD).	zno-dox	85-92	hemopexin	Sus scrofa	16-21
31468717-4	2019	In this design, HAase is encapsulated on the surfaces of doxorubicin (DOX) preloaded ZnO-DOX NPs using a charge convertible polymer PEG-PAH-DMMA (ZDHD).	peg-pah-dmma	132-144	hemopexin	Sus scrofa	16-21
28533108-0	2017	Hyaluronidase administered with xylazine-tiletamine-zolazepam into adipose tissue shortens recovery from anesthesia in pigs.	xylazine-tiletamine-zolazepam	32-61	hemopexin	Sus scrofa	0-13
28533108-1	2017	OBJECTIVE: To evaluate the effect of hyaluronidase on uptake, duration and speed of elimination of xylazine-tiletamine-zolazepam administered in the subcutaneous fat over the dorsal lumbar region of swine.	xylazine-tiletamine-zolazepam	99-128	hemopexin	Sus scrofa	37-50
28166932-6	2017	Porcine PBMCs bind to Poly (I:C)-treated cells and this binding is dependent on HA, since the increase in adhesion is abolished by hyaluronidase treatment of the cell layers.	Carbon	30-32	hemopexin	Sus scrofa	131-144
23624064-0	2013	Hyaluronidase: its effects on HI-6 dichloride and dimethanesulphonate pharmacokinetic profile in pigs.	asoxime chloride	30-45	hemopexin	Sus scrofa	0-13
27768920-7	2017	In addition, the presence of haptoglobin, hemopexin, alpha-1 acid glycoprotein and fetuin-A, that are known as acute-phase reaction proteins, was observed, suggesting that CPFA resins led to a non-specifically protein depletion from plasma, rather than targeting specific molecules.	cpfa	172-176	hemopexin	Sus scrofa	42-51
23624064-0	2013	Hyaluronidase: its effects on HI-6 dichloride and dimethanesulphonate pharmacokinetic profile in pigs.	dimethanesulphonate	50-69	hemopexin	Sus scrofa	0-13
23624064-6	2013	Bioavailability calculated as AUCtotal (HI-6 DMS with hyaluronidase, 4,119 +- 647 min mug/ml) was also significantly higher compared to HI-6 DMS (2,259 +- 329 min mug/ml) and HI-6 dichloride (1,969 +- 254 min mug/ml); both without hyaluronidase.	hi-6 dms	40-48	hemopexin	Sus scrofa	54-67
23624064-7	2013	The results suggest that administration of HI-6 salt with higher solubility is the first step in the improvement of application strategy, but use some substances with spreading effect (hyaluronidase) may also leads to better absorption and better bioavailability.	hi-6 salt	43-52	hemopexin	Sus scrofa	185-198
16243482-2	2006	Echinacoside is a caffeoyl conjugate of Echinacea with known anti-hyaluronidase properties.	echinacoside	0-12	hemopexin	Sus scrofa	66-79
16243482-2	2006	Echinacoside is a caffeoyl conjugate of Echinacea with known anti-hyaluronidase properties.	caffeoyl	18-26	hemopexin	Sus scrofa	66-79
17593452-12	2008	CONCLUSIONS: Hyaluronidase gel reduces post-operative peritoneal adhesions ratio and grades including in the presence of polypropylene mesh.	Polypropylenes	121-134	hemopexin	Sus scrofa	13-26
15218248-1	2004	Hyaluronidase genes (HYAL) encode hyaluronidase enzymes required for hyaluronan degradation.	Hyaluronic Acid	69-79	hemopexin	Sus scrofa	0-13
15218248-1	2004	Hyaluronidase genes (HYAL) encode hyaluronidase enzymes required for hyaluronan degradation.	Hyaluronic Acid	69-79	hemopexin	Sus scrofa	34-47
15218248-14	2004	For all three hyaluronidase genes, N-glycosylation sites are typical.	Nitrogen	35-36	hemopexin	Sus scrofa	14-27